Bank Julius Baer & Co. Ltd, Zurich Glaukos Corp Transaction History

Bank Julius Baer & Co. Ltd, Zurich

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$47.43 - $84.23 $588,748 - $1.05 Million	-12,413 Closed	0 $0
Q2 2021 Jul 23, 2021	SELL	$73.06 - $97.7 $154,375 - $206,440	-2,113 Reduced 14.55%	12,413 $1.05 Million
Q1 2021 May 10, 2021	BUY	$70.43 - $97.42 $769,306 - $1.06 Million	10,923 Added 303.16%	14,526 $1.22 Million
Q1 2020 May 13, 2020	BUY	$25.53 - $70.14 $91,984 - $252,714	3,603 New	3,603 $111,000

342

46.8M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.45B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.